Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Source outlook
2.2.2. Derivatives outlook
2.2.3. Cultivation outlook
2.2.4. End Use outlook
2.3. Competitive Insights
Chapter 3. Market Variables, Trends, and Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. U.S. Cannabis Market - Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis Tools: U.S. Cannabis Market
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTLE Analysis
3.4. Current Market Trends in Cannabis Industry
3.5. Regulatory Scenario
3.6. Licensing Scenario in the U.S.
3.7. Cannabis Consumption Pattern Analysis
3.8. Legal Cannabis Potential Trade Opportunity
3.9. Legal Cannabis Seed to Shelf Story
3.10. Supply Chain Analysis
3.11. Legal Cannabis Industry: U.S. Country Case Studies
3.12. Guidelines and Requirements for Cannabis Cultivation
3.13. Cannabis Facility Design and Equipment Requirements
3.14. Government Policy Designing Cannabis Guidelines
3.14.1. Federal Cannabis Policy
3.14.2. Policy Challenges and Opportunities
3.15. Reimbursement Policies in the U.S
3.16. Taxation Policies in The U.S.
Chapter 4. U.S. Cannabis Market: Source Estimates & Trend Analysis
4.1. Definition and Scope
4.2. Source Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. U.S. Cannabis Market, by Source, 2018 to 2030
4.5. Marijuana
4.5.1. Marijuana Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Flower Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2.1. Flower Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Oil and Tinctures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3.1. Oil and Tinctures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Hemp
4.6.1. Hemp Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.2. Hemp Oil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.2.1. Hemp Oil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.3. Industrial Hemp Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.3.1. Industrial Hemp Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. Cannabis Market: Derivative Estimates & Trend Analysis
5.1. Definition and Scope
5.2. Derivative Market Share Analysis, 2024 & 2030
5.3. Segment Dashboard
5.4. U.S. Cannabis Market, by Derivative, 2018 to 2030
5.5. CBD
5.5.1. CBD Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. THC
5.6.1. THC Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. U.S. Cannabis Market: Cultivation Estimates & Trend Analysis
6.1. Definition and Scope
6.2. Cultivation Market Share Analysis, 2024 & 2030
6.3. Segment Dashboard
6.4. U.S. Cannabis Market, by Cultivation, 2018 to 2030
6.5. Indoor Cultivation
6.5.1. Indoor Cultivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Greenhouse Cultivation
6.6.1. Greenhouse Cultivation Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Outdoor Cultivation
6.7.1. Outdoor Cultivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. U.S. Cannabis Market: End Use Estimates & Trend Analysis
7.1. Definition and Scope
7.2. End Use Market Share Analysis, 2024 & 2030
7.3. Segment Dashboard
7.4. U.S. Cannabis Market, by End Use, 2018 to 2030
7.5. Medical Use
7.5.1. Medical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Cancer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2.1. Cancer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Chronic Pain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3.1. Chronic Pain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. Depression and Anxiety Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4.1. Depression and Anxiety Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. Arthritis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5.1. Arthritis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6. Diabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6.1. Diabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. Glaucoma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7.1. Glaucoma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.8. Migraines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.8.1. Migraines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.9. Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.9.1. Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.10. Multiple Sclerosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.10.1. Multiple Sclerosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.11. AIDS Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.11.1. AIDS Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.12. Amyotrophic Lateral Sclerosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.12.1. Amyotrophic Lateral Sclerosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.13. Alzheimers's Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.13.1. Alzheimers's Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.14. Post Traumatic Stress Disorder (PTSD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.14.1. Post Traumatic Stress Disorder (PTSD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.15. Parkinson's Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.15.1. Parkinson's Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.16. Tourettes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.16.1. Tourettes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.17. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.17.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Recreational Use
7.6.1. Recreational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Industrial Use
7.7.1. Industrial Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. U.S. Cannabis Market: Competitive Landscape
8.1. Participant’s Categorization
8.2. Company Market Position Analysis, 2024
8.3. Strategy Mapping
8.4. Company Profiles
8.4.1. Charlotte's Web, Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Medical Marijuana, Inc.
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Canopy Growth Corporation
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. NuLeaf Naturals, LLC
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. CV Sciences, Inc.
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. The Cronos Group
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Organigram Holding, Inc.
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Irwin Naturals
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Tilray Brands
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Aurora Cannabis Inc.
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. cannabis market, by source, 2018 - 2030 (USD Million)
Table 4 U.S. cannabis market, by derivatives, 2018 - 2030 (USD Million)
Table 5 U.S. cannabis market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. cannabis market, by cultivation, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Value-chain-based sizing & forecasting
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market research approaches
Fig. 7 Market formulation & validation
Fig. 8 U.S. cannabis market: market outlook
Fig. 9 U.S. cannabis competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook.
Fig. 12 Industry value chain analysis
Fig. 13 U.S. cannabis market driver impact
Fig. 14 U.S. cannabis market restraint impact
Fig. 15 U.S. cannabis market strategic initiatives analysis
Fig. 16 U.S. cannabis market: Source movement analysis
Fig. 17 U.S. cannabis market: Source outlook and key takeaways
Fig. 18 Hemp market estimates and forecasts, 2018 - 2030
Fig. 19 Hemp Oil market estimates and forecasts, 2018 - 2030
Fig. 20 Industrial Hemp market estimates and forecasts, 2018 - 2030
Fig. 21 Marijuana market estimates and forecasts, 2018 - 2030
Fig. 22 Flower market estimates and forecasts, 2018 - 2030
Fig. 23 Oil and Tinctures market estimates and forecasts, 2018 - 2030
Fig. 24 U.S. cannabis market: Derivatives movement analysis
Fig. 25 U.S. cannabis market: Derivatives outlook and key takeaways
Fig. 26 CBD market estimates and forecasts, 2018 - 2030
Fig. 27 THC market estimates and forecasts, 2018 - 2030
Fig. 28 Others market estimates and forecasts, 2018 - 2030
Fig. 29 U.S. cannabis market: Cultivation movement analysis
Fig. 30 U.S. cannabis market: Cultivation outlook and key takeaways
Fig. 31 Indoor Cultivation market estimates and forecasts, 2018 - 2030
Fig. 32 Greenhouse Cultivation market estimates and forecasts, 2018 - 2030
Fig. 33 Outdoor Cultivation market estimates and forecasts, 2018 - 2030
Fig. 34 U.S. cannabis market: End-use movement analysis
Fig. 35 U.S. cannabis market: End-use outlook and key takeaways
Fig. 36 Industrial Use market estimates and forecasts, 2018 - 2030
Fig. 37 Medical Use market estimates and forecasts, 2018 - 2030
Fig. 38 Chronic Pain market estimates and forecasts, 2018 - 2030
Fig. 39 Depression and Anxiety market estimates and forecasts, 2018 - 2030
Fig. 40 Arthritis market estimates and forecasts, 2018 - 2030
Fig. 41 Post Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2018 - 2030
Fig. 42 Cancer market estimates and forecasts, 2018 - 2030
Fig. 43 Migraines market estimates and forecasts, 2018 - 2030
Fig. 44 Epilepsy market estimates and forecasts, 2018 - 2030
Fig. 45 Alzheimer’s market estimates and forecasts, 2018 - 2030
Fig. 46 Multiple Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 47 AIDS market estimates and forecasts, 2018 - 2030
Fig. 48 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 49 Tourette’s market estimates and forecasts, 2018 - 2030
Fig. 50 Diabetes market estimates and forecasts, 2018 - 2030
Fig. 51 Parkinson's market estimates and forecasts, 2018 - 2030
Fig. 52 Glaucoma market estimates and forecasts, 2018 - 2030
Fig. 53 Others market estimates and forecasts, 2018 - 2030
Fig. 54 Recreational Use market estimates and forecasts, 2018 - 2030
Fig. 55 Key company categorization
Fig. 56 Heatmap Analysis, 2024